The activation of HER2 causes un-regulated activation of the PI3K/AKT and Ras/Raf/MAPK pathways and the consequent development of various forms of cancer such as breast, lung, uterine, cervix, stomach, ovary, colon, bladder, and oesophagus [47]. Here, ERBB2 is linked to cancer.